Cargando…

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors

The emergence of untreatable drug‐resistant strains of Mycobacterium tuberculosis is a major public health problem worldwide, and the identification of new efficient treatments is urgently needed. Mycobacterium tuberculosis cytochrome P450 CYP121A1 is a promising drug target for the treatment of tub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishk, Safaa M., McLean, Kirsty J., Sood, Sakshi, Smith, Darren, Evans, Jack W.D., Helal, Mohamed A., Gomaa, Mohamed S., Salama, Ismail, Mostafa, Samia M., de Carvalho, Luiz Pedro S., Levy, Colin W., Munro, Andrew W., Simons, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646865/ https://www.ncbi.nlm.nih.gov/pubmed/31367508 http://dx.doi.org/10.1002/open.201900227

Ejemplares similares

Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1
por: Kishk, Safaa M., et al.
Publicado: (2019)

Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation
por: Taban, Ismail M., et al.
Publicado: (2017)

Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
por: Kavanagh, Madeline E., et al.
Publicado: (2016)

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors
por: Alshabani, Lama A., et al.
Publicado: (2022)

Pyrazole, imidazole and triazole: In silico, docking and ADMET studies against SARS-CoV-2
por: Mohamed, Mounir, et al.
Publicado: (2023)

Overcoming the Limitations of Fragment Merging: Rescuing a Strained Merged Fragment Series Targeting Mycobacterium tuberculosis CYP121
por: Hudson, Sean A., et al.
Publicado: (2013)

Structure‐Activity Relationship and Mode‐Of‐Action Studies Highlight 1‐(4‐Biphenylylmethyl)‐1H‐imidazole‐Derived Small Molecules as Potent CYP121 Inhibitors
por: Walter, Isabell, et al.
Publicado: (2021)

Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis
por: Kumar, Amit, et al.
Publicado: (2021)

A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen)
por: Frederickson, Martyn, et al.
Publicado: (2022)

Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)

Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of Mycobacterium tuberculosis
por: Bajrai, Leena Hussein, et al.
Publicado: (2022)

Pyrazole and Triazole Derivatives as Mycobacterium tuberculosis UDP-Galactopyranose Inhibitors
por: Ahmed, Dalia M., et al.
Publicado: (2022)

Coordination Complexes Built from a Ditopic Triazole-Pyrazole Ligand with Antibacterial and Antifungal Performances
por: Draoui, Youssef, et al.
Publicado: (2023)

Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
por: Niculescu-Duvaz, Dan, et al.
Publicado: (2010)

Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus
por: Seck, Insa, et al.
Publicado: (2021)

Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents
por: Chu, Ming-Jie, et al.
Publicado: (2019)

Synthesis and Characterization of Novel 2-(1,2,3-Triazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazoles and 2-(4,5-Dihydro-1H-pyrazol-1-yl)-4-(1H-1,2,3-triazol-4-yl)thiazoles
por: Kariuki, Benson M., et al.
Publicado: (2022)

Biofragments: An Approach towards Predicting Protein Function Using Biologically Related Fragments and its Application to Mycobacterium tuberculosis CYP126
por: Hudson, Sean A, et al.
Publicado: (2014)

Analysis of imidazoles and triazoles in biological samples after MicroExtraction by packed sorbent
por: Campestre, Cristina, et al.
Publicado: (2017)

Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies
por: Kishk, Safaa M., et al.
Publicado: (2020)

Structural and catalytic properties of the peroxygenase P450 enzyme CYP152K6 from Bacillus methanolicus
por: Girvan, Hazel M., et al.
Publicado: (2018)

(19)F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis
por: Campomizzi, Christopher S., et al.
Publicado: (2021)

Half-lives of $^{121}$Cs and $^{121}$In isomers
por: Scheidemann, Ø, et al.
Publicado: (1974)

Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein
por: Nagy, Manar I., et al.
Publicado: (2021)

Synthesis and Evaluation of Baylis-Hillman Reaction Derived Imidazole and Triazole Cinnamates as Antifungal Agents
por: Nelson, Grady L., et al.
Publicado: (2018)

Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
por: Fakhry, Mariam M., et al.
Publicado: (2022)

Selective, Tunable O(2) Binding in Cobalt(II)–Triazolate/Pyrazolate Metal–Organic Frameworks
por: Xiao, Dianne J., et al.
Publicado: (2016)

New 1,2,3-Triazole-Appended Bis-pyrazoles: Synthesis, Bioevaluation, and Molecular Docking
por: Danne, Ashruba B., et al.
Publicado: (2021)

Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens
por: Novak-Frazer, Lilyann, et al.
Publicado: (2020)

Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51
por: Shi, Na, et al.
Publicado: (2020)

Memorandum 121
por: Barloutaud, R
Publicado: (1978)

Design, Synthesis, and In Vitro and In Vivo Antifungal Activity of Novel Triazoles Containing Phenylethynyl Pyrazole Side Chains
por: Ni, Tingjunhong, et al.
Publicado: (2022)

The decay of /sup 121/Xe (/sup 121/I deduced levels)
por: Münnich, F, et al.
Publicado: (1972)

Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
por: Al-blewi, Fawzia, et al.
Publicado: (2021)

Expression of the retinoic acid catabolic enzyme CYP26B1 in the human brain to maintain signaling homeostasis
por: Stoney, Patrick N., et al.
Publicado: (2015)

Memorandum: merging of the P121 and P123 Collaboration
por: Tallini, Bruno, et al.
Publicado: (1979)

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)
por: Adeniji, Shola Elijah, et al.
Publicado: (2018)

The decay of $^{121}$Xe
por: Münnich, F, et al.
Publicado: (1972)

Expression, Purification, and Biochemical Characterization of the Flavocytochrome P450 CYP505A30 from Myceliophthora thermophila
por: Baker, George J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h4t99moqhnip4clrq3pb9tv66l